Wednesday, September 1, 2021

Zydus Cadila – Walk-In Interviews for Multiple Openings on 04th and 05th Sept’ 2021

 Zydus Cadila – Walk-In Interviews for Multiple Openings on 04th & 05th Sept’ 2021


Zydus Cadila is an innovation driven global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies,including small molecules, biologic therapeutics and vaccines. Zydus was the first company in India to develop and indigenously manufacture the vaccine to combat Swine Flu during the pandemic in 2010. The group also launched Twinrab TM which is a first of its kind, next-gen therapy for treating rabies in collaboration with WHO. Among the other firsts, the company was the first anywhere in the world to get an approval for Sarogitazar for the treatment of unmet healthcare needs like Diabetic Dysplipidemia, Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH) and Non-Alcoholic Fatty Liver Disease in India. Saroglitazar has also received Orphan Drug Designation from the USFDA and European Medicines Agency for Primary Biliary Cholangitis (PBC). The company also launched Ujvira (Trastuzumab Emtansine), a breakthrough in Breast Cancer treatment and the world's first biosimilar Ansbody Drug Conjugate of Trastuzumab Emtansine. Recently, the group received the EUA forZyCoV-D, the world's first Plasmid DNA vaccine to fight COVID-19 in India.

Interested candidates may also email their resume to purvishpatel@zyduscadila.com or send it by courier to the Human Resource Department, Zydus Research Centre, Near Nova Petrochemical Ltd., Village - Moraiya, Changodar, Ahmedabad-382210 within 7 days.


close